[153Sm]EDTMP: A potential therapy for bone cancer pain

The Direct Synthesis of α-Aminomethylphosphonic Acids. Mannich-Type Reactions with Orthophosphorous Acid

1966 • 470 citations

Skeletal localization of samarium-153 chelates: potential therapeutic bone agents.

1987 • 208 citations

Human pharmacokinetics of samarium-153 EDTMP in metastatic cancer.

1989 • 150 citations

Re-186(Sn) HEDP for treatment of multiple metastatic foci in bone: human biodistribution and dosimetric studies.

1988 • 129 citations

Subacute and chronic bone infections: diagnosis using In-111, Ga-67 and Tc-99m MDP bone scintigraphy, and radiography.

1985 • 129 citations

Treatment of metastatic bone pain with strontium-89

1987 • 104 citations

Therapy in Nuclear Medicine

1978 • 101 citations

Samarium ? 153 EDTMP therapy of disseminated skeletal metastasis

1989 • 100 citations

Clinical and clinicopathologic response of canine bone tumor patients to treatment with samarium-153-EDTMP.

1990 • 79 citations

153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals

1987 • 68 citations

Radiation dose calculations in persons receiving injection of samarium-153 EDTMP.

1987 • 62 citations

Rare earth nuclides as potential agents for skeletal imaging.

1969 • 50 citations

Iodine-131-labeled diphosphonates for palliative treatment of bone metastases: II. Preliminary clinical results with iodine-131 BDP3.

1986 • 45 citations

RADIOLABELED PHOSPHONIC ACID CHELATES: POTENTIAL THERAPEUTIC AGENTS FOR TREATMENT OF SKELETAL METASTASES

1989 • 31 citations

Clinical and clinicopathologic effects of samarium-153-EDTMP administered intravenously to normal beagle dogs.

1990 • 30 citations

Strontium 89 for palliation of bone metastases.

1986 • 24 citations

Phosphorus-32 for intractable pain in carcinoma of prostate

1977 • 22 citations

Yttrium-90 zur Schmerztherapie von Knochenmetastasen

1981 • 12 citations

Determination of lesion to normal bone uptake ratios of skeletal radiopharmaceuticals by QARG

1991 • 9 citations